Toll Free: 1-888-928-9744
Published: Feb, 2014 | Pages:
42 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Torrent Pharmaceuticals Limited - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Torrent Pharmaceuticals Limited - Product Pipeline Review - 2014', provides an overview of the Torrent Pharmaceuticals Limited's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Torrent Pharmaceuticals Limited's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Torrent Pharmaceuticals Limited including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Torrent Pharmaceuticals Limited's human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Torrent Pharmaceuticals Limited's pipeline products Reasons to buy - Evaluate Torrent Pharmaceuticals Limited's strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Torrent Pharmaceuticals Limited in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Torrent Pharmaceuticals Limited's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Torrent Pharmaceuticals Limited and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Torrent Pharmaceuticals Limited - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Torrent Pharmaceuticals Limited and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Torrent Pharmaceuticals Limited Snapshot 5 Torrent Pharmaceuticals Limited Overview 5 Key Information 5 Key Facts 5 Torrent Pharmaceuticals Limited - Research and Development Overview 6 Key Therapeutic Areas 6 Torrent Pharmaceuticals Limited - Pipeline Review 9 Pipeline Products by Stage of Development 9 Pipeline Products - Monotherapy 10 Pipeline Products - Combination Treatment Modalities 11 Torrent Pharmaceuticals Limited - Pipeline Products Glance 12 Torrent Pharmaceuticals Limited - Late Stage Pipeline Products 12 Phase III Products/Combination Treatment Modalities 12 Torrent Pharmaceuticals Limited - Clinical Stage Pipeline Products 13 Phase II Products/Combination Treatment Modalities 13 Phase I Products/Combination Treatment Modalities 14 Torrent Pharmaceuticals Limited - Early Stage Pipeline Products 15 Preclinical Products/Combination Treatment Modalities 15 Discovery Products/Combination Treatment Modalities 16 Torrent Pharmaceuticals Limited - Drug Profiles 17 (esomeprazole magnesium + levosulpiride) 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 TRC-150094 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 TRC-4186 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 TRC-160334 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 Dual Action Receptor Antagonists 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 TRC-051384 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 TRC-120038 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 TRC-210258 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 Small Molecule For COPD 27 Product Description 27 Mechanism of Action 27 R&D Progress 27 Small Molecule For Diabetes 28 Product Description 28 Mechanism of Action 28 R&D Progress 28 Small Molecule For Neuropathic Pain 29 Product Description 29 Mechanism of Action 29 R&D Progress 29 Torrent Pharmaceuticals Limited - Pipeline Analysis 30 Torrent Pharmaceuticals Limited - Pipeline Products by Target 30 Torrent Pharmaceuticals Limited - Pipeline Products by Route of Administration 32 Torrent Pharmaceuticals Limited - Pipeline Products by Molecule Type 33 Torrent Pharmaceuticals Limited - Pipeline Products by Mechanism of Action 34 Torrent Pharmaceuticals Limited - Dormant Projects 36 Torrent Pharmaceuticals Limited - Locations And Subsidiaries 37 Head Office 37 Other Locations & Subsidiaries 37 Appendix 41 Methodology 41 Coverage 41 Secondary Research 41 Primary Research 41 Expert Panel Validation 41 Contact Us 42 Disclaimer 42
List of Tables Torrent Pharmaceuticals Limited, Key Information 5 Torrent Pharmaceuticals Limited, Key Facts 5 Torrent Pharmaceuticals Limited - Pipeline by Indication, 2014 8 Torrent Pharmaceuticals Limited - Pipeline by Stage of Development, 2014 9 Torrent Pharmaceuticals Limited - Monotherapy Products in Pipeline, 2014 10 Torrent Pharmaceuticals Limited - Combination Treatment Modalities in Pipeline, 2014 11 Torrent Pharmaceuticals Limited - Phase III, 2014 12 Torrent Pharmaceuticals Limited - Phase II, 2014 13 Torrent Pharmaceuticals Limited - Phase I, 2014 14 Torrent Pharmaceuticals Limited - Preclinical, 2014 15 Torrent Pharmaceuticals Limited - Discovery, 2014 16 Torrent Pharmaceuticals Limited - Pipeline by Target, 2014 31 Torrent Pharmaceuticals Limited - Pipeline by Route of Administration, 2014 32 Torrent Pharmaceuticals Limited - Pipeline by Molecule Type, 2014 33 Torrent Pharmaceuticals Limited - Pipeline Products by Mechanism of Action, 2014 35 Torrent Pharmaceuticals Limited - Dormant Developmental Projects,2014 36 Torrent Pharmaceuticals Limited, Other Locations 37 Torrent Pharmaceuticals Limited, Subsidiaries 39
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.